Metabolic

Activity Levels in US Teens and Older Adults

Activity Levels in US Teens and Older Adults

Physical activity levels among children and teens are lower than previously thought.

Systolic Blood Pressure Variability Independently Predicts CV Events and Death in Diabetes

Systolic Blood Pressure Variability Independently Predicts CV Events and Death in Diabetes

By

Visit-to-visit systolic blood pressure variability may be a better predictor of cardiovascular events and death than traditional risk factors.

Cholesterol Significantly Reduced by Blocking Angiopoietin-like 3 Gene

Cholesterol Significantly Reduced by Blocking Angiopoietin-like 3 Gene

Two research groups successfully reduced cholesterol in humans to block the angiopoietin-like 3 gene.

US Packaged Food Manufacturers Reduced Sodium Amounts

US Packaged Food Manufacturers Reduced Sodium Amounts

Consumers are purchasing food items containing less sodium and manufacturers are decreasing the amount of sodium in their products.

Cardiovascular Disease Risk Reduced With Healthy Fats

Cardiovascular Disease Risk Reduced With Healthy Fats

Replacing saturated fats with polyunsaturated fats and monounsaturated fats can reduce cardiovascular disease risk.

Cardiovascular Stress in Type 2 Diabetes Reduced With Canagliflozin

Cardiovascular Stress in Type 2 Diabetes Reduced With Canagliflozin

By

American Diabetes Association presented a study that Canagliflozin could possibly decrease cardiovascular stress in older patients with type 2 diabetes.

CV Risks in Obesity and Diabetes Not Increased With Nalxtrexone/Bupropion

CV Risks in Obesity and Diabetes Not Increased With Nalxtrexone/Bupropion

By

Two studies found that extended-release naltrexone/bupropion did not increase cardiovascular risks for patients with type 2 diabetes.

Risk of Cardiovascular Disease High With 'Healthy' Obesity

Risk of Cardiovascular Disease High With 'Healthy' Obesity

People with metabolically healthy obesity still have a higher risk of cardiovascular disease.

Intensive Glucose Control in Diabetes Reduces Kidney and Eye Events

Intensive Glucose Control in Diabetes Reduces Kidney and Eye Events

By

Kidney and eye events in type 2 diabetes were reduced with more intensive glucose control.

Medical Weight Management Program: Covered vs Self-Pay

Medical Weight Management Program: Covered vs Self-Pay

Paying out-of-pocket for a weight management program is not associated with significant weight loss difference compared to those with insurance coverage.

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

Effect of Obesity Paradox on Venous Thromboembolism Risk in Atrial Fib

By

A meta-analysis was conducted to examine concerns surrounding direct oral anticoagulant therapy in patients with extreme high or low body weight.

Glucagon-Like Peptide-1 Receptor Agonists May Lower Cardiovascular Risk in Type 2 Diabetes

Glucagon-Like Peptide-1 Receptor Agonists May Lower Cardiovascular Risk in Type 2 Diabetes

By

Glucagon-like peptide-1 receptor agonist therapy was associated with lower risk for acute MI, stroke, and all-cause mortality.

Frequent Hot Flashes Give Cardiovascular Insight In Young Women

Frequent Hot Flashes Give Cardiovascular Insight In Young Women

By

Frequent hot flashes in younger women were linked to endothelial function, providing more insight into the cardiovascular disease risk status of patients.

Overweight/Obesity Affects Brain Function in Type 2 Diabetes

Overweight/Obesity Affects Brain Function in Type 2 Diabetes

By

Overweight or obese patients with type 2 diabetes mellitus are more likely to show severe and progressive brain function and cognition abnormalities.

Dietary Approaches to Stop Hypertension Diet May Lower Risk of Gout

Dietary Approaches to Stop Hypertension Diet May Lower Risk of Gout

The Dietary Approaches to Stop Hypertension diet has been found to effectively prevent gout.

Lowering LDL Cholesterol HIV: Pitavastatin vs Pravastatin

Lowering LDL Cholesterol HIV: Pitavastatin vs Pravastatin

By

Pitavastatin had greater low-density lipoprotein-lowering effects than pravastatin.

Diabetes Risk Predicted by Cardiometabolic Disease Staging Score

Diabetes Risk Predicted by Cardiometabolic Disease Staging Score

The Cardiometabolic Disease Staging score can effectively quantify the risk of diabetes and predict the effectiveness of weight-loss therapy for preventing diabetes in overweight and obese patients.

Low HbA1c After Metformin Initiation Lowers CV Risks in T2D Patients

Low HbA1c After Metformin Initiation Lowers CV Risks in T2D Patients

By

A large, initial reduction in hemoglobin A1c (HbA1c) and achievement of low HbA1c levels 6 months after metformin initiation lowered the risk for cardiovascular events and death in patients with type 2 diabetes.

Severe Hypoglycemia Affects Short-Term Mortality in Type 2 Diabetes

Severe Hypoglycemia Affects Short-Term Mortality in Type 2 Diabetes

By

The majority of patients with diabetes requiring hospitalization for severe hypoglycemia were patients with type 2 diabetes.

Acute MI In-Hospital Mortality Rates in Type 2 Diabetes

Acute MI In-Hospital Mortality Rates in Type 2 Diabetes

By

Patients with type 1 diabetes admitted for acute myocardial infarction had higher mortality rates compared with patients with type 2 diabetes.

Fasting vs Nonfasting Lipid Values and Cardiovascular Risk: Q&A With Advisory Board Member, Eliot Brinton, MD

Fasting vs Nonfasting Lipid Values and Cardiovascular Risk: Q&A With Advisory Board Member, Eliot Brinton, MD

By

Eliot Brinton, MD, FAHA, FNLA, president and director of the Utah Lipid Center, discusses the benefits of fasting lipid profiles in predicting cardiovascular risk.

Effect of Avocados on Metabolic Syndrome Components

Effect of Avocados on Metabolic Syndrome Components

By

Avocado consumption most affected LDL, HDL, and total cholesterol, triglycerides, and phospholipids.

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

By

Compared with New York counties without trans fatty acid restrictions, those with restrictions showed a significantly greater decline in combined myocardial infarction and stroke events.

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

Lower HbA1c Post-PCI Promotes Better Outcomes in Diabetes

By

Patients with HbA1c levels had lower 7-year incidence of major adverse cardiac and cerebrovascular events compared with patients with higher HbA1c levels.

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

Glucose Levels May Affect Functional Outcomes After Endovascular Thrombectomy

By

The effect of hypoglycemia on functional outcomes after endovascular thrombectomy differs, depending on collateral status.

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

By

Increases in body weight fluctuations were associated with greater risk for coronary and cardiovascular events and death.

Cardiometabolic Comorbidities Found in Majority of Inpatients With Schizophrenia, Bipolar Disorder

Cardiometabolic Comorbidities Found in Majority of Inpatients With Schizophrenia, Bipolar Disorder

By

Study results emphasize the importance of identifying optimal treatment regimens for patients with serious mental illness.

Sacubitril/Valsartan Improves Glycemic Control in Comorbid Heart Failure and Diabetes

Sacubitril/Valsartan Improves Glycemic Control in Comorbid Heart Failure and Diabetes

By

HbA1c decreased by 0.16% in the enalapril group vs 0.26% in the sacubitril/valsartan group.

Coronary Artery Disease Risk Elevated With Genetic Hyperglycemia

Coronary Artery Disease Risk Elevated With Genetic Hyperglycemia

Elevated coronary artery disease risk is independent of type 2 diabetes and other CAD risk factors.

Higher BMI Linked With Lower Mortality in Adult Congenital Heart Disease

Higher BMI Linked With Lower Mortality in Adult Congenital Heart Disease

By

Higher BMI was associated with lower all-cause and cardiac mortality in adults with congenital heart disease, even after adjusting for age, defect complexity, cyanosis, and objective exercise capacity.

Sign Up for Free e-Newsletters